Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors
Conditions
Head and Neck Squamous Cell Carcinoma · Squamous Cell Carcinoma of Anal Canal · Colorectal Cancer · Squamous Cell Carcinoma of the Lung · EGFR Amplification · Epithelial Ovarian Cancer · Pancreas Cancer · Cutaneous Squamous Cell Carcinoma · Head and Neck Neoplasms · Carcinoma, Squamous Cell · Squamous Cell Carcinoma of Head and Neck
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Moores Cancer Center UC San Diego Health, La Jolla, California, United States
Contact: Principal Investigator (Assuntina Sacco, MD)Keck School of Medicine of USC, Los Angeles, California, United States
Contact: Principal Investigator (Gino In, MD)UCLA, Los Angeles, California, United States
Contact: Principal Investigator (Deborah Wong, MD)University of California, Davis Comprehensive Cancer Center, Sacramento, California, United States
Contact: Study coordinator (Andrew Birkeland, MD)Contact: Principal Investigator (Andrew Birkeland, MD)H. Lee Moffitt Cancer Center and Research Institute, Inc, Tampa, Florida, United States
Contact: Principal Investigator (Christine Chung, MD)Dana Farber/Partners Cancer Care Inc, Boston, Massachusetts, United States
Contact: Principal Investigator (Glenn Hanna, MD)Memorial Sloan Kettering, New York, New York, United States
Contact: Principal Investigator (Paul Paik, MD)Columbia University Herbert Irving Comprehensive Cancer Center, New York, New York, United States
Contact: Study coordinator (CPDM Nurse Navigator) · cancerclinicaltrials@cumc.columbia.edu · 2123425162Contact: Principal Investigator (Catherine Shu, MD)Levine Cancer Institute, Charlotte, North Carolina, United States
Cleveland Clinic, Cleveland, Ohio, United States
Contact: Principal Investigator (Tamara Sussman, MD)UPMC Hillman Cancer Center, Pittsburgh, Pennsylvania, United States
Contact: Principal Investigator (Dan Zanberg, MD)Rhode Island Hospital, Providence, Rhode Island, United States
Contact: Principal Investigator (Ariel Birnbaum, MD)Medical University of South Carolina, Hollings Cancer Center, Charleston, South Carolina, United States
Contact: Principal Investigator (John Kaczmar, MD)Vanderbilt University Medical Center, Nashville, Tennessee, United States
Contact: Principal Investigator (Jennifer Choe, MD, PhD)MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Van Morris, MD)Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia
Contact: Study coordinator (Jenny Lee, MBBS, FRACP)Contact: Principal Investigator (Jenny Lee, MBBS, FRACP)Calvary Mater Newcastle, Waratah, New South Wales, Australia
Contact: Principal Investigator (Fiona Day)Austin Hospital, Heidelberg, Victoria, Australia
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
Contact: Principal Investigator (Danny Rischin, MD)Princess Margaret Cancer Centre, Toronto, Ontario, Canada
Contact: Principal Investigator (Phillippe Bedard, MD)